← Back to Clinical Trials
Recruiting NCT06692244

Efficacy and Safety of Additive Manufacturing Personalized Titanium Mesh in Guided Bone Regeneration

Trial Parameters

Condition Alveolar Bone Atrophy
Sponsor Hospital of Stomatology, Sun Yat-Sen University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 142
Sex ALL
Min Age 18 Years
Max Age 60 Years
Start Date 2024-11-30
Completion 2027-12
Interventions
Guided Bone Regeneration Surgery Using Additive-Manufactured Personalized Titanium MeshGuided Bone Regeneration Surgery Using Prefabricated Titanium Mesh

Brief Summary

This goal of this single-blind, simple randomized, positive-controlled prospective study is to evaluate the effects of additive-manufactured personalized titanium mesh and traditional titanium mesh in guided bone regeneration for large alveolar bone defects. The study will assess the short-term and long-term efficacy, safety, and incidence of complications of the additive-manufactured personalized titanium mesh, along with an analysis of risk factors. Participants will be followed up for two years after surgery with free-of-charge clinical and radiographic examinations.

Eligibility Criteria

Inclusion Criteria: 1. Patients missing single or multiple teeth with moderate to severe bone defects in the edentulous area requiring complex guided bone regeneration. (Moderate bone defects: bone loss with residual alveolar ridge width between 1 mm and 3 mm; severe bone defects: bone loss with residual alveolar ridge width ≤ 1 mm.) 2. The edge of the edentulous area within 1 mm is alveolar bone, with no adjacent tooth roots or nerve canals, ensuring complete retention of the personalized titanium mesh edge. The apical edge of the edentulous area within 2 mm is alveolar bone, with no nerve canals, ensuring that retention screws for the personalized titanium mesh can be designed in this area. 3. The patient and/or his/her guardian agrees to participate in this trial and signs the informed consent form. Exclusion Criteria: 1. Patients with edentulism. 2. Patients with mild bone defects (residual alveolar ridge width greater than 3 mm). 3. Presence of acute or chronic infection in the su

Related Trials